Stock comparison
Novartis AG is 12.8x more valuable than INSMED Inc by market capitalization ($309.21 B vs $24.10 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
NVS is larger
Novartis AG is 12.8x more valuable than INSMED Inc by market capitalization ($309.21 B vs $24.10 B).
Market value leader
NVS
Novartis AG is 12.8x more valuable than INSMED Inc by market capitalization ($309.21 B vs $24.10 B).
| Metric | INSM | NVS |
|---|---|---|
| Market cap | $24.10 B | $309.21 B |
| US-listed rank | #544 | #38 |
| Revenue (latest FY) | $606.42M | - |
| Net income (latest FY) | -$1.28B | - |
| Net margin | -210.5% | - |
| P/E (trailing FY) | - | - |
| SEC filings | 1,774 | 953 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Novartis AG is 12.8x more valuable than INSMED Inc by market capitalization ($309.21 B vs $24.10 B).
Full pages: INSMED Inc and Novartis AG, or browse the full rankings.